SOPH
SOPHiA GENETICS SA
NASDAQ · Healthcare · Medical - Healthcare Information Services · CH
$8.19
−3.99%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 6.58x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 8.39x
- Price / sales
- 8.09x
- Price / cash flow
- -16.76x
Enterprise value
- Enterprise value
- $651.4M
- EV / sales
- 7.56x
- EV / EBITDA
- -10.00x
- EV / EBIT
- -8.89x
- Market cap
- $697.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026